ResearcherHirosaki UniversityActive in the last 2 years
Tadashi Yoshizawa
Matched on ORCID iD 0000-0001-8136-3281; OpenAlex author ID A5000890115. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2021: 3 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.humpath.2026.106238↗
- Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemothera… First author DOI 10.3892/or.2023.8498↗
- Roles of the nervous system in pancreatic cancer. Co-author DOI 10.1002/ags3.12459↗
- Eukaryotic initiation factor 2 signaling behind neural invasion linked with lymphatic and vascular invasion in pancreatic cancer. Co-author DOI 10.1038/s41598-021-00727-3↗
- Time density curve of dynamic contrast-enhanced computed tomography correlates with histological characteristics of pancreatic cancer. Co-author DOI 10.3892/ol.2021.12537↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kenichi Hakamada · 5 shared papers, 2021–2026 · strength 0.87
- Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
- Paper Roles of the nervous system in pancreatic cancer. DOI 10.1002/ags3.12459↗
- Paper Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological thera… DOI 10.3892/or.2023.8498↗
- Keinosuke Ishido · 5 shared papers, 2021–2026 · strength 0.87
- Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
- Paper Roles of the nervous system in pancreatic cancer. DOI 10.1002/ags3.12459↗
- Paper Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological thera… DOI 10.3892/or.2023.8498↗
- Hiroshi Kijima · 4 shared papers, 2021–2026 · strength 0.70
- Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
- Paper Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological thera… DOI 10.3892/or.2023.8498↗
- Paper Time density curve of dynamic contrast-enhanced computed tomography correlates with histological characteristics of pan… DOI 10.3892/ol.2021.12537↗
- Shintaro Goto · 3 shared papers, 2021–2026 · strength 0.58
- Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
- Paper Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological thera… DOI 10.3892/or.2023.8498↗
- Paper Time density curve of dynamic contrast-enhanced computed tomography correlates with histological characteristics of pan… DOI 10.3892/ol.2021.12537↗
- Kenta Ogasawara · 2 shared papers, 2023–2026 · strength 0.43
- Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
- Paper Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological thera… DOI 10.3892/or.2023.8498↗
- Hayato Nagase · 2 shared papers, 2021–2026 · strength 0.38
- Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
- Paper Eukaryotic initiation factor 2 signaling behind neural invasion linked with lymphatic and vascular invasion in pancreat… DOI 10.1038/s41598-021-00727-3↗
- Taishu Kanda · 2 shared papers, 2021 · strength 0.29
- Taiichi Wakiya · 2 shared papers, 2021 · strength 0.29
- Yusuke Wakasa · 1 shared paper, 2026 · strength 0.26
- Satoru Tsuruta · 1 shared paper, 2026 · strength 0.26
- Yoshiki Nishiyama · 1 shared paper, 2026 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.